Administration with hyperoside sensitizes breast cancer cells to paclitaxel by blocking the TLR4 signaling

Published 2020 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Administration with hyperoside sensitizes breast cancer cells to paclitaxel by blocking the TLR4 signaling
Authors
Keywords
Breast cancer, Chemosensitivity, Hyperoside, TLR4 pathway, Paclitaxel
Journal
MOLECULAR AND CELLULAR PROBES
Volume 53, Issue -, Pages 101602
Publisher
Elsevier BV
Online
2020-05-22
DOI
10.1016/j.mcp.2020.101602

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.